Source-traceable intelligence for CBRN, nonproliferation, UAV and counter-UAS regulations, official guidance, training and trusted research—organized so professionals can act with confidence.
Every insight links back to an authoritative source. AI helps classify, compare and synthesize evidence without replacing the underlying record.
Treaties, OPCW materials, chemical security, toxic industrial chemicals, dual-use controls and preparedness.
Explore domain →Biosafety & biosecurityBWC implementation, laboratory biosafety, biosecurity, responsible science and biological preparedness.
Explore domain →Source securityRadioactive source security, transport, detection, emergency preparedness and incident management.
Explore domain →Nuclear securityPhysical protection, nuclear security regimes, IAEA guidance, safeguards interfaces and nuclear forensics.
Explore domain →Aviation & policyCivil and government UAS regulation, Remote ID, airspace integration, strategy and dual-use policy.
Explore domain →Defensive governanceCounter-UAS policy, legal authorities, interagency roles, critical infrastructure and incident management.
Explore domain →Emerging threatsDefensive research on UAS-enabled CBRN risks, preparedness, prevention, policy and response.
Explore domain →WMD controlsUNSCR 1540, strategic trade controls, export controls, sanctions, illicit procurement and proliferation prevention.
Explore domain →European Union Aviation Safety Agency
EASA's consolidated Easy Access Rules combine the EU UAS regulatory text with acceptable means of compliance and guidance material in navigable PDF, online, and machine-readable formats and are updated as the framework evolves.
Federal Aviation Administration
FAA guidance and training pathway for obtaining and maintaining a Remote Pilot Certificate under Part 107, including no-cost recurrent online training required to maintain aeronautical knowledge recency.
Centers for Disease Control and Prevention / National Institutes of Health
The sixth edition of BMBL is advisory U.S. biosafety guidance built around protocol-driven risk assessment and best practices for safe work in biomedical and clinical laboratories; it is not itself a regulatory document.
Aegis preserves source authority, versions, prior URLs, relationships and update evidence so professionals can distinguish what is current, what changed, and why it matters.
Ask Aegis